Novel use of a Clinical Laboratory Improvements Amendments (CLIA)-certified Cyclin-Dependent Kinase N2C (CDKN2C) loss assay in sporadic medullary thyroid carcinoma
Titel:
Novel use of a Clinical Laboratory Improvements Amendments (CLIA)-certified Cyclin-Dependent Kinase N2C (CDKN2C) loss assay in sporadic medullary thyroid carcinoma
Auteur:
Maxwell, Jessica E. Gule-Monroe, Maria K. Subbiah, Vivek Hu, Mimi Perrier, Nancy D. Cabanillas, Maria E. Lee, Jeffery E. Graham, Paul H. Cote, Gilbert J. Busaidy, Naifa L. Grubbs, Elizabeth G.